Drug Pipeline

18F-florbetaben Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT05184088
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis		 Trial completed
2026-06-03 NCT05184088
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis		 Enrollment increased: 200 -> 244 participants
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-03 NCT07624760 Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging Not Yet Recruiting
Active Studies by Phase
Phase 2
1
Phase 1
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04840979 Discovery and Validation of Genetic Variants Affecting Microglial Activation in… Alzheimer Disease Active, Not Recruiting
Phase 1
NCT04396873 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease Parkinson's Disease Recruiting
NCT07169630 PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or… Alzheimer s Disease Recruiting
Not specified
NCT03507257 Longitudinal Early-onset Alzheimer's Disease Study Protocol Early Onset Alzheimer Disease Recruiting
NCT07624760 Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging Monoclonal Gammopathy Not Yet Recruiting
Sponsors Running 18F-florbetaben Trials
National Institute of Mental Health (NIMH) (2) Indiana University (1) Columbia University (1) University of Zurich (1)
Disease Areas
Alzheimer's Disease (4) Dementia (1) Parkinson's Disease (1) ALS (1) Multiple Myeloma (1) Amyloidosis (1)
Get alerts when 18F-florbetaben trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free